PortViewPortView
IsoPlexis logo

IsoPlexis (ISO) Stock Analysis

NASDAQHealthcareMedical - Devices

$0.76+0.00%
1-year price historyRange $0.66 – $4.63
52-week range$0.76
$0.60$3.84

What IsoPlexis does

IsoPlexis Corporation is a life sciences company dedicated to advancing the development of novel curative treatments and personalized therapeutics. The company's innovative offerings serve a wide international market, spanning North America (United States, Canada), numerous European nations (United Kingdom, Belgium, France, Czech Republic, Spain, Germany, Sweden, Italy, Switzerland), and key Asian and Pacific regions (Israel, China, Taiwan, Singapore, Japan, Australia, Korea). At its core, IsoPlexis provides a proprietary single-cell proteomics platform. This comprehensive system integrates specialized instruments, consumable chips, and advanced software, delivering an end-to-end solution for observing protein activity and function at the individual cellular level. Its instrument lineup includes the IsoLight and IsoSpark systems. For chip consumables, it offers IsoCode chips, designed for multiplexed single-cell functional proteomics, and CodePlex chips, which provide multiplexed analysis for ultra-low volume bulk samples. The IsoSpeak software further enhances the platform, providing robust dimensional data analysis and automating workflows through an intuitive, push-button user interface. This enables rapid, same-day visualization of both single-cell and bulk proteome data. Beyond its core products, IsoPlexis also extends research support and post-warranty services. Established in 2013, the company operates from its base in Branford, Connecticut.

Key metrics

Market cap
$30.28M
P/E (TTM)
-0.30
EPS (TTM)
$-2.55
Beta
0.00
Dividend yield
0.00%
Revenue / share
$0.43
50-day avg
$1.07
200-day avg
$1.74
52-week high
$3.84
52-week low
$0.60
CEO
Sean Mackay

ETFs linked to ISO

Broad-market and Healthcare sector ETFs an investor holding IsoPlexis is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ISO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ISO in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for IsoPlexis?
IsoPlexis trades under the ticker ISO on NASDAQ.
Which exchange is ISO listed on?
ISO is listed on NASDAQ.
What sector does IsoPlexis operate in?
IsoPlexis is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze ISO in a portfolio?
PortView shows ISO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.